Tempest Therapeutics, Inc. 8-K

What Happened

• Tempest Therapeutics, Inc. (TPST) announced on May 6, 2026 that it posted an updated corporate presentation dated May 6, 2026 to the “News, Events & Presentations” subsection of the Investors tab on its website (www.tempesttx.com). The company also issued a press release on the same date. These disclosures were furnished in a Form 8‑K dated May 6, 2026 (Items 7.01 and 8.01).

Key Details

• Item 7.01 (Regulation FD Disclosure): Updated corporate presentation posted to the company website on May 6, 2026.
• Item 8.01 (Other Events): Press release dated May 6, 2026 was furnished and is included as Exhibit 99.1 to the Form 8‑K.
• Exhibits filed: 99.1 (press release), 99.2 (corporate presentation dated May 2026), and 104 (Inline XBRL cover page).

Why It Matters

• For investors, the filing signals that Tempest has provided refreshed investor materials and a contemporaneous press release; those documents may contain updated strategic, programmatic, or operational information that could be material. Investors should review the posted presentation and press release on the company’s investor website or in the Form 8‑K exhibits for any details that could affect valuation or investment decisions.